Withdrawal from nicotine can cause anxiety and despair upon quitting
(The Centers for Disease Control and Prevention reminds us that it might contain delicious arsenic, lead, and mercury.) But the public has a right to know
While CMS is not required to provide a preliminary report, CMS seeks to facilitate manufacturer understanding of the Rebate Report and believes it would be beneficial for manufacturers to review the report for mathematical errors that could be corrected before invoicing via the Rebate Report
We expect reduced reporting burden for clinicians who previously reported at least one medium-weighted activity
Differential assessment Cannabis dependence must be differentiated from: Cannabis abuse / harmful use without dependence features Cannabis-induced psychiatric conditions (e.g., psychosis, mood disorders) Other substance use disorders or comorbid conditions Accurate diagnosis requires thorough history-taking, standardized screening tools (e.g., CUDIT-R), collateral reports when available, and clear documentation of symptom onset, course, and functional impact